Pakistan Tehreek-e-Insaf founder Imran Khan received his fourth intravitreal anti-vascular endothelial growth factor injection at the Pakistan Institute of Medical Sciences on Tuesday and was discharged the same day in clinically stable condition, hospital authorities said.

According to a statement issued by the hospital, the 74-year-old former prime minister was brought from Adiala Jail for a scheduled follow-up procedure related to his right eye condition. Prior to the injection, ophthalmologists conducted a clinical examination and found him stable. An Optical Coherence Tomography scan reportedly showed signs of improvement.

The procedure was carried out in an operation theatre under microscopic guidance, with standard monitoring and precautionary protocols in place. It was performed as a day-care surgery. Khan remained stable before, during and after the treatment and was later discharged with medical instructions and follow-up advice, the statement added.

This marks the latest in a series of treatments following his diagnosis of central retinal vein occlusion, a serious eye condition affecting blood flow in the retina and commonly associated with underlying cardiovascular risk factors such as hypertension, diabetes and high cholesterol. According to medical reports submitted in court proceedings, Khan has reportedly experienced significant vision impairment in his right eye.

He first underwent treatment in January, followed by subsequent injections in February and March, as part of an ongoing treatment plan monitored by doctors at the state-run hospital.

The development comes amid continuing political tension between Khan’s Pakistan Tehreek-e-Insaf and the government, with the opposition raising concerns over his medical care in custody and demanding treatment under the supervision of private physicians. The government has rejected allegations of inadequate care.

© Naya Daur